The Biden administration has relaunched its program sending free COVID-19 tests in the mail.{beacon} Health Care Health Care ...

BioNTech has launched global clinical trials for BNT116, an mRNA vaccine designed to treat non-small cell lung cancer.

Along with the annual flu vaccine, the new COVID-19 vaccine formulation is now widely available in Minnesota. It comes at a ...

The Covid booster jab autumn scheme is opening in just a few days with some Brits eligible and encouraged to get their ...

We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP ...

The BioNTech SE ADR BNTX rallied 1.59% to $117.64 Thursday, on what proved to be an all-around favorable trading session for ...

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

Free at-home COVID-19 tests are now available for families across the nation. As of Thursday, families are now able to obtain up to four free COVID-19 tests through the U.S. Department of Health and ...

The announcement comes as the administration is trying to encourage people to get the updated COVID-19 vaccines from ...

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

Firms faced off at two trials in London earlier this year centred on the use of messenger RNA (mRNA) technology in ...

OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger. | ...